[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100360901":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":20,"responsibleParty":43,"collaborators":7,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":7,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":57,"studyType":58,"phases":7,"briefSummary":59,"conditions":60,"keywords":7,"overallStatus":23,"whyStopped":7,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"University Hospital, Geneva","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"PROCEDURE","Lung tumor resection","lung tumor resection",[14],{"name":15,"role":16,"phone":17,"phoneExt":18,"email":19},"Veronique SERRE-BEINIER, PhD","CONTACT","(0)223795107","+41","veronique.serre-beinier@hcuge.ch",[21],{"facility":22,"status":23,"city":24,"state":7,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Geneva University Hospitals","RECRUITING","Geneva","1205","Switzerland","CH",{"type":29,"coordinates":30},"Point",[31,32],6.14569,46.20222,{"lat":32,"lon":31},[35,38,41],{"name":15,"role":16,"phone":36,"phoneExt":37,"email":19},"223795107","41",{"name":39,"role":40,"phone":7,"phoneExt":7,"email":7},"Frederic TRIPONEZ, MD","PRINCIPAL_INVESTIGATOR",{"name":42,"role":40,"phone":7,"phoneExt":7,"email":7},"Wolfram KARENOVICS, MD",{"type":40,"investigatorFullName":44,"investigatorTitle":45,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Frederic TRIPONEZ","Professor","100360901","patient-derived-organoids-of-lung-cancer-to-test-drug-response-100360901",false,"NCT03979170","Patient-derived Organoids of Lung Cancer to Test Drug Response","Inclusion Criteria:\n\n* Histologically proven lung cancer\n* Age ≥ 18\n* Written informed and signed consent\n* Accessible to biopsy and\u002For surgery sample of metastasis and\u002For primitive tumour\n\nExclusion Criteria:\n\n* Less than 18 years of age\n* Not able to give informed consent (language, intellectual capacities, etc.)\n* Not accessible to biopsy and\u002For surgery sample\n* Not enough lung tissue for a histological analysis or the remaining lung tissue is not enough to perform a routine pathological analysis.","ALL","18 Years",{"count":55,"type":56},50,"ESTIMATED","1 Day","OBSERVATIONAL","This is a single center, single arm, open and exploratory clinical study, with 50 cases planned for a period of 3 years. The purpose of this study is to evaluate the consistency and accuracy of a Patient-Derived Organoid (PDO) Model of lung cancer to predict the clinical efficacy of anti-cancer drugs, in order to predict the best chemotherapy regimen for each given patient.",[61,62],"Lung Cancer","Organoid","2024-05-31",{"date":65,"type":66},"2024-06-03","ACTUAL",{"date":68,"type":66},"2019-04-01",{"date":70,"type":56},"2029-12-30",{"name":5,"class":6},1]